Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
Remaining TC-5214 Phase III efficacy studies do not meet endpoint, regulatory filing will not be pursued
-
AstraZeneca files lawsuit against the FDA for decision regarding quetiapine product labelling and exclusivity
-
FDA responds to AstraZeneca Citizen Petitions on quetiapine product labelling
-
AstraZeneca announces Non-Executive changes, retirement of Chairman and appointment of successor
-
FDA approves first four-strain flu vaccine
-
European Commission approves CAPRELSA® (vandetanib) for patients with advanced medullary thyroid cancer
-
AstraZeneca PLC Fourth quarter and full year results 2011
-
AstraZeneca’s new restructuring initiatives to drive productivity and support innovation
-
AstraZeneca and Bristol-Myers Squibb receive complete response letter from US Food and Drug Administration for dapagliflozin
-
AstraZeneca and IMS Health announce real-world evidence collaboration in Europe
Latest articles and press releases
All of our latest press releases and articles are available to explore
